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Abstract 
Magnetic resonance imaging (MRI) studies have shown subtle differences of brain anatomy between 
people with major depressive disorder (MDD) and healthy controls, but few studies have specifically 
examined brain anatomical asymmetry in relation to this disorder, and results from those studies 
have remained inconclusive. Asymmetry is a subtle but pervasive aspect of the human brain, and it 
may be altered in several psychiatric conditions. At the functional level, some 
electroencephalography studies have indicated left fronto-cortical hypo-activity and right parietal 
hypo-activity in depressive disorders, so that aspects of lateralized anatomy might also be affected. 
In the current study, we investigated 2256 individuals with MDD and 3504 controls, from 31 separate 
datasets, for differences in the laterality of thickness and surface area measures of 34 cerebral 
cortical regions. We also investigated volume asymmetries of eight subcortical structures, in 2540 
MDD individuals and 4230 controls, from 32 datasets. T1-weighted MRI data were processed with a 
single protocol using FreeSurfer software and the Desikan-Killiany atlas. The unprecedented sample 
size provided 80% power to detect effects of the order of Cohen’s d = 0.1. However, the largest effect 
size of MDD diagnosis was Cohen’s d = 0.085 for the thickness asymmetry of the superior temporal 
cortex, which was not significant when adjusting for multiple testing. Asymmetry measures were also 
not significantly associated with medication use, acute versus remitted status, first episode versus 
recurrent status, or age at onset. Altered brain macro-anatomical asymmetry may therefore be of 
little relevance to MDD aetiology in most cases. 
Keywords: laterality, left-right asymmetry, major depressive disorder, MRI   
7 
 
Introduction 
Major Depressive Disorder (MDD) is a common and debilitating psychiatric disorder, characterized by 
a persistent feeling of sadness or a lack of interest in outside stimuli (DSM-V) (1). The disorder is 
often characterized by recurrent episodes and can become a chronic condition (2). Worldwide, 
lifetime prevalence varies considerably. A WHO World Mental Health survey across 18 countries 
found an average lifetime prevalence ranging from 6.6% in Japan to 21.0% in France, with an average 
lifetime prevalence of 14.6% across high-income countries (3). 
Much of the neurobiology of MDD is unknown, but subtle alterations of brain structure may be 
involved, and various MRI-based studies have observed regional brain differences between MDD 
individuals and healthy controls. A recent review of the literature by Zhang (4) described various 
possible structural alterations in the brains of MDD individuals, such as case-control differences in 
the thickness of the medial orbitofrontal cortex and inferior parietal gyrus. However, it was also 
noted that the results of structural MRI studies in MDD have often been inconsistent (4). This  
inconsistency is likely due to the use of small study sample sizes in relation to subtle effects, and also 
heterogeneity among studies in terms of clinical characteristics and methodological aspects. For 
example, hardware and software differences between scanners and distinct data processing 
pipelines can contribute to heterogeneity (5). 
In the ENIGMA (Enhancing Neuro-Imaging Genetics through Meta-Analysis) consortium 
(http://enigma.ini.usc.edu), researchers from around the world collaborate to analyse many separate 
datasets jointly, and to reduce some of the technical heterogeneity by using harmonized MRI 
preprocessing protocols. Two recent studies by the ENIGMA consortium’s MDD working group 
showed differences in cerebral cortical and subcortical brain structures between more than 1700 
MDD individuals and 7000 controls. Relative to controls, MDD individuals had significantly smaller 
hippocampal volumes (6). In addition, adults with MDD had thinner cortical grey matter than 
controls in the orbitofrontal cortex, anterior and posterior cingulate cortex, insula and temporal 
lobes (7), and adolescent MDD individuals had a lower total cortical surface area than age-matched 
controls, driven particularly by regional reductions of the medial orbitofrontal cortex and superior 
frontal gyrus, as well as primary and higher-order visual, somatosensory and motor surface areas (7).  
Left-right asymmetry is an important aspect of human brain organization, that may be altered in 
various psychiatric and neurocognitive conditions, including schizophrenia, autism and dyslexia (8-
10). There are indications that altered brain asymmetry might also play a role in MDD. On a 
functional level, EEG studies have reported that asymmetry in frontal brain resting activity differs 
between MDD individuals and healthy controls, although not always in a consistent direction, and 
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moderated by age and sex (see e.g. (11-14), reviewed in (15, 16)). Such findings have led to the 
development of stimulation protocols targeted at the left dorso-lateral prefrontal cortex, which are 
now used in the clinic for the treatment of MDD (17). Moreover, a recent review considered studies 
based on dichotic listening, visual hemifield analysis, electrophysiology, and neuroimaging, and 
concluded that there was evidence for reductions of left frontal and right parietotemporal function in 
depressive disorders (18). A reduction of left frontal activity is in accordance with 
approach/withdrawal models of MDD, in which the normal balance of left frontal activity underlying 
positive reactions to positive stimuli, and right frontal activity underlying negative reactions to 
negative stimuli, might be disturbed (19, 20). 
Some of the average brain anatomical differences between MDD individuals and controls, described 
in the review by Zhang et al.(4), involved only one of the two hemispheres. Zhang et al. concluded 
that the right medial orbitofrontal cortex was often found to be thinner in MDD individuals than 
controls, while the volumes of the left middle frontal gyrus and the right thalamus were lower in 
MDD individuals (4). The ENIGMA consortium study of the cerebral cortex found, in adults, that the 
thickness of the inferior temporal gyrus and caudal anterior cingulate was significantly thinner in 
MDD individuals only on the right side, but not on the left (7). However, in these analyses it was not 
tested whether effect sizes of diagnosis were significantly different on the left and right sides, nor 
was asymmetry quantified as a trait in its own right. Rather, the unilateral patterns were reported on 
the basis that one hemisphere achieved statistical significance against the null hypothesis of no 
effect of diagnosis, and the other side did not. Such patterns can reflect insufficient statistical power 
to detect small but uniform bilateral effect sizes, and do not necessarily indicate differences in brain 
laterality per se. Furthermore, to analyze asymmetry alterations in MDD, a post hoc statistical 
comparison of the left and right-sided effect sizes reported by the previous studies would not yield 
the same level of statistical power as can be provided by utilizing the individual-level paired left and 
right data. Meanwhile the ENIGMA study of subcortical volumes did not consider left and right 
hemisphere measures separately, as they were combined together for bilateral averages (6). 
Brain structural asymmetry in MDD has only been investigated in a small number of individual 
studies with limited sample sizes. These include a study of grey matter volume of the dorsolateral 
prefrontal cortex in 39 treatment-naive MDD individuals, 31 medicated MDD individuals, and 49 
controls, in which the treatment-naive individuals had increased rightward asymmetry (i.e., the 
extent of right>left asymmetry was larger) relative to controls (21). Another study reported that the 
frontal lobe volume was on average less rightward asymmetric in MDD individuals (N=34) than in 
controls (N=30) (22). No large-scale studies of brain asymmetry in MDD have been performed to 
date. 
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To systematically investigate structural asymmetries in the brains of MDD individuals vs healthy 
controls, we used data available through the ENIGMA consortium’s MDD Working Group, and 
targeted brain regional and global hemispheric lateralities as assessed by the asymmetry index 
AI=(Left-Right)/(Left+Right). In healthy populations, some regional brain asymmetries show mean sex 
differences (23, 24). In addition, MDD is often reported to be more common in women than men; for 
example, a sex ratio of 1.6:1 was found in a Canadian survey (25). The disorder can also present 
differently in men and women (25, 26). These observations prompted us to perform secondary -
analyses separately by sex. Furthermore, some structural brain differences between MDD individuals 
and controls were found to be distinct between adolescent and adult groups (see above)(7). 
Asymmetries of the brain also change with age in healthy populations, for some subcortical (23) and 
cortical regions (24). We therefore carried out secondary analyses in separate subgroups of MDD 
individuals and controls under and over age 21 years at the time of scanning. As MDD is a clinically 
heterogeneous disorder, we also tested whether structural brain asymmetries are different in 
medicated versus non-medicated MDD individuals, acute MDD individuals versus those in remission, 
first episode MDD individuals versus those with recurrent episodes, or in relation to age at onset of 
the disorder.   
Methods 
Datasets 
For this study, we pooled individual-level data from 32 non-overlapping datasets collected around 
the world, of which one dataset included only subcortical volumes, and all others had both 
subcortical and cerebral cortical measures. See Online supplement Table S1 for the geographic 
locations and demographics of the different samples. All participating sites obtained approval from 
local institutional review boards and ethics committees, and all study participants provided written 
informed consent. 
In total, the combined dataset for cortical measures contained 2256 MDD individuals and 3504 
controls after local quality control at each centre (see below), but before central quality control, 
which was performed specifically for the present study (further explained below). The combined 
dataset for subcortical measures consisted of 2540 cases and 4230 controls, before central quality 
control. Eleven of the study centres contributing to this analysis were also involved in the previous 
study of cortical differences between MDD individuals and controls (7), while eight of the current 
study centres also contributed to the previous ENIGMA MDD subcortical study (6). The mean age at 
sampling across datasets was 37.1 years (s.d. 16.1) for MDD individuals and 39.0 (s.d. 17.3) for 
controls, respectively. Of the MDD individuals, 36% were male, and of the controls 47% were male. 
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Descriptive information per dataset is presented in Online supplement Table S1, and diagnostic 
instruments are described in Online supplement Table S2. Data on antidepressant medication use at 
time of scanning, recurrent episodes, acute versus remitted status, and age of MDD onset can be 
found per dataset In Online supplement Table S3. 
Image processing 
Structural T1-weighted brain MRI scans were acquired at each study site. Images were acquired at 
different field strengths (1.5 T or 3 T), and with various acquisition parameters as shown in Online 
supplement Table S4. All sites then applied harmonized processing and quality control protocols 
developed or adopted by the ENIGMA consortium (http://enigma.ini.usc.edu/protocols/imaging-
protocols). The data used in the current study were left and right volumes of eight bilaterally paired 
subcortical structures (strictly seven subcortical structures plus the lateral ventricles), and thickness 
and surface area measures for each of 34 bilaterally paired cortical regions, the latter as defined with 
the Desikan-Killiany atlas (27). In addition, the average cortical thickness and total surface area per 
entire hemisphere were analysed. Subcortical segmentation and cortical parcellations were 
performed with the freely available and validated software FreeSurfer (versions 5.1 or 5.3) (28, 29). 
Parcellation of cortical grey matter regions were visually inspected and statistically evaluated for 
outliers following the standardized ENIGMA protocol (http://enigma.ini.usc.edu/protocols/imaging-
protocols). 
Data preparation, visualization and statistical analysis 
De-identified data were sent from all datasets to a central analysis team. As a measure of asymmetry 
for each bilaterally paired measure, we then calculated the asymmetry index: AI=(L-R)/(L+R), where L 
and R are the left and right measures, respectively. Thus, positive and negative AI values indicate 
leftward and rightward asymmetry, respectively. It is important to note that in the definition of the 
AI, the difference (i.e., L-R) was normalized by use of the bilateral measure as denominator (i.e., L+R), 
such that the measure does not scale with the overall magnitude of L and R. For this reason, we did 
not adjust for intracranial volume in our analyses. Furthermore, we were interested to detect the full 
extent of any case-control effects on AIs, without removing variance in the AIs that might be 
correlated with other brain measures potentially affected in MDD. 
Quality control at the sites had excluded individual datapoints. Centrally, subjects with more than 
four entries missing for the eight subcortical volumes were excluded from the analysis of subcortical 
regions, as having possibly unreliable subcortical data. Similarly, subjects with more than eight 
missing values out of 34 regional cortical thickness measures were removed altogether from the 
analysis of cortical thickness, and likewise for surface area measures. Exclusion of subjects by this 
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step varied from 1% of both MDD individuals and controls for the subcortical data, up to 3% of 
controls for the surface area data. The total remaining numbers were, 3399 controls and 2217 MDD 
individuals for the cortical surface areas, 3427 controls and 2229 MDD individuals for the cortical 
thickness values, and 4185 controls and 2517 MDD individuals for the subcortical volumes. The 
numbers of individual missing values then varied by structure: from 0.16% missing values for the 
surface area of the lateral orbitofrontal cortex to 14.3% missing values for the surface area of the 
entorhinal cortex: Full numbers can be found in Online supplement Table S5. 
To prevent large effects of possible outliers, all AIs were winsorized to 2.2 times the inter-quartile 
range, as recommended in (30). Frequency histograms of each AI are shown in Supp. Figure 1. The 
per-dataset means for each AI were computed, and multidimensional scaling-plots were created 
separately for cortical thickness AIs, cortical surface AIs, and subcortical volume AIs, to visualize 
whether any datasets were obvious outliers in terms of their population-level laterality, as 
considered over multiple regions.  
Using individual-level data from all available datasets, for each structure separately, a linear mixed 
model was fitted using R (version 3.4.0), with AI as the dependent variable, and Sex, Age, Age2 and 
Diagnosis (MDD or control) as fixed factors, with ‘dataset’ as a random factor (random intercept). As 
Age and Age2 are highly correlated, we made use of the poly()-function in R for these two predictors, 
which created a pair of uncorrelated variables to model age effects (so-called orthogonal 
polynomials)(31), where one variable was linear and one non-linear’. Model fit was checked visually 
by inspection of the plots of residuals vs fitted values, and the QQ plots for the residual values. 
Cook’s distance plots by dataset (R command CookD (lme_model, group="dataset") were used to 
visualize whether any of the datasets were obvious outliers at the level of individual structures. To 
interpret the results of our analysis, we used a false discovery rate (FDR) of 0.05 within all AIs of a 
given structural measure, so separately within 35 cortical thickness AIs, 35 cortical surface area AIs, 
and eight subcortical volume AIs. A global FDR assessment was also planned, over all AIs tested in the 
main analysis of all subjects, but no effects of diagnosis on AIs proved significant within the separate 
FDR corrections (see Results), so that a global assessment was not needed. We calculated Cohen’s d 
for the effect size of diagnosis on each AI, as t*sqrt(1/n1 + 1/n2), where n1 and n2 are the sample 
sizes of the MDD individuals and the controls respectively, and t is the t statistic for the diagnosis 
term in the model for a given AI. Brain anatomical figures were generated using Freesurfer functions 
and triangular surface plotting (trisurf) in Matlab R2015b, with the Cohen’s d statistics for cortical 
regions projected onto the pial surface. 
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We used the pwr() command in R to calculate a priori the minimal effect size that we had 80% power 
to detect with the available data. (As each linear model included multiple predictor variables, 
including a random effect, the a priori power could not be computed exactly, but this calculation 
assumed the use of simple t-tests to provide a useful indication). For the cortical measures we set a 
significance level of 0.001 (roughly 0.05/35 in the context of multiple testing over all 34 regional AIs 
and one global hemispheric AI). This showed that the indicative minimum effect at 80% power was 
Cohen’s d=0.112. For the subcortical AIs (corrected at 0.05/8=0.006), the indicative minimum effect 
at 80% power was d=0.090.  
For secondary analysis of the effects of MDD diagnosis on AIs within demographic subsets, we 
separated the data into females only, males only, individuals ≤ 21 years of age or individuals >21 
years at the time of scanning. The same linear mixed model as above was applied to each of these 
subsets separately, except that the factor ‘sex’ was not included for the male- or female-only 
subsets.  
Secondary analyses of AIs in relation to clinical variables were carried out within MDD individuals 
only (see Supp. Table S3). For binary clinical variables (recurrent versus first episode, medicated 
versus un-medicated with antidepressants at time of scanning, acute versus remitted), we used the 
same linear mixed model approach described above, except now replacing the diagnosis status with 
the binary clinical variable in question. For this purpose we only included datasets with at least ten 
MDD individuals of each subgroup. Age at onset within MDD individuals was tested as a linear effect 
on AIs, otherwise using the same linear mixed model as for the main analysis. See Supp. Tables S6a-c 
and S7a-c for the sample sizes used for each linear mixed model in these secondary analyses. FDR 
adjusted p-values are presented, for the 8 (subcortical) or 35 (cortical) AIs within each separate 
analysis. 
Results 
MDS-plots based on per-dataset AI means showed that none of the datasets were extreme outliers, 
viewed across all brain structures (Supp. Figure 2). 
In the main analysis (all MDD individuals versus controls), no significant effects of diagnosis were 
found for any of the cortical thickness, cortical surface or subcortical volume AIs, after multiple 
testing correction (Tables 1-3, Table S5). The subset analyses by age and sex also showed no 
significant effects of diagnoses on AIs (Tables 1-3, Table S5). A small number of nominal (unadjusted) 
P values for effects of diagnosis on AIs were below 0.01, but none survived FDR correction for 
multiple comparisons. The strongest effect of diagnosis on asymmetry in the main analysis was for 
13 
 
the superior temporal gyrus thickness asymmetry, with an unstandardised effect of diagnosis on AI 
(i.e. the mean AI difference between cases and controls after adjustment for the other model effects) 
of 0.002, nominal (unadjusted) p=0.003, Cohen’s d = 0.085. For this region, the right surface area was 
larger than the left in controls, and also in cases but to a lesser extent (Table S5). Similar effects were 
found for the caudal anterior cingulate thickness AI (Cohen’s d = 0.079; L>R in controls and more so 
in cases) and the cuneus surface area asymmetry (Cohen’s d = -0.081; R>L in controls and more so in 
cases)(Table S5). Some of the subset analyses also produced nominally significant effects, such as for 
hippocampal volume asymmetry in males only (Cohen’s d = -0.112) (Tables 1-3, Table S5). However, 
in the context of multiple testing, these cannot be considered reliable effects. Full model results are 
included in Table S5. 
We visualized the Cohen’s d values from the main analyses (all subjects combined, i.e. the left-most 
columns of Tables 2 and 3) against a cortical brain image, to help assess whether any multi-region 
patterns were discernible which might have spanned neighbouring regions, or corresponded with the 
frontal-occipital or dorso-ventral axes (Figure 1). No clear patterns were visible.  
The analysis of clinical variable effects on AIs within MDD individuals (Supp. Tables 6abc-7abc) 
showed only one significant P value <0.05 after multiple testing adjustment: the cortical thickness of 
the fusiform gyrus was more rightward asymmetric in persons using antidepressants at time of 
scanning (adjusted p-value 0.046). However, this p-value was only adjusted within this particular 
analysis (i.e., 35 cortical thickness AIs tested for effects of medication use) and should be interpreted 
with care, given the degree of study-wide testing involved. Full results from these analyses can be 
found in Supp. Tables 6abc-7abc. 
Discussion 
In this study, no significant differences of brain structural asymmetry were found between 
individuals with MDD and unaffected controls, for any cerebral cortical or subcortical asymmetry 
measure, in an unprecedented sample size of over 5,000 subjects. Power analysis indicated that we 
had 80% power a priori to detect a case-control Cohen’s d of roughly 0.1 for a given AI, in the main 
analysis. However, the strongest effect of diagnosis involved Cohen’s d = 0.085 for the superior 
temporal gyrus thickness AI, which was too subtle to be statistically significant when considering 
multiple testing, even with this large sample size (adjusted P value of 0.104). There were similarly 
small and non-significant changes of caudal anterior cingulate thickness asymmetry (Cohen’s d = 
0.079) and cuneus surface area asymmetry (Cohen’s d =  -0.081). We are not aware of previous 
findings in the literature which are concordant with these effects. If differences in the asymmetry of 
brain structures between individuals with MDD and unaffected controls do exist, they were too small 
14 
 
to be detected reliably in this analysis. Our study illustrates the importance of taking large-scale and 
systematic approaches to the study of brain-disorder associations. 
We found no support for alterations of asymmetry that are consistent with those reported in two 
previous, small studies (see Introduction) of the dorsolateral prefrontal cortex (21) or frontal lobe 
(22). In our data, sub-regions that are part of the dorsolateral prefrontal cortex showed merely 
tentative case-control differences for cortical surface area, in opposite directions across sub-regions 
(Figure 1). It may therefore be that the earlier studies reported false positive findings in the context 
of small datasets, although the cortical atlas that we used did not have a perfect equivalent for the 
measures defined in these studies, and we did not consider grey matter volumes as such. Rather, we 
studied regional cortical thicknesses and surface areas as distinct measures, which together drive 
grey matter volumetric measures, but have been shown to vary relatively independently (32), such 
that separate analyses are well motivated.  
The possibility remains that altered brain functional or structural asymmetry might be related, as 
cause, correlate or effect, to MDD in some etiological subgroups of individuals. The previous ENIGMA 
consortium analyses of brain structural changes in MDD (in which asymmetry was not investigated; 
see Introduction) found case-control differences particularly in the context of multiple episodes of 
depression and/or in relation to age of onset of depression (6, 7). One possibility is therefore that 
brain changes in MDD may be driven by long-term stress associated with the disorder. Following our 
main analysis, we sub-divided the data by sex and age groups, and we also analyzed various clinical 
variables within MDD individuals (recurrent versus first episode, on antidepressant medication versus 
antidepressant-free at time of scanning, acute versus remitted, age at onset), but found no 
convincing evidence for effects within these subgroups. Sample sizes for these secondary analyses 
were reduced relative to the main analysis, due to either subsetting or limited availability of clinical 
variables (Supp. Tables S6a-S7c), while multiple testing for these secondary analyses was substantial. 
We found one tentative effect involving thickness asymmetry of the fusiform gyrus, with respect to 
medication status of MDD individuals (FDR adjusted P= 0.046). In a previous study, medication naïve 
persons with MDD (N=37) showed a greater thickness of the left fusiform gyrus than healthy controls 
(N=41)(33), while in our analysis, MDD individuals using antidepressant medication had a rightward 
change of thickness asymmetry of the fusiform cortex compared to MDD individuals that were not 
using antidepressants at time of scanning. Given the degree of multiple testing in our secondary 
analyses, and that this finding has no previous support in the literature, we regard it as tentative. 
Furthermore, we had no systematic information on past use of medication or other treatments, nor 
dose levels at the time of scanning, both of which may relate to disorder duration and severity, such 
that this finding must be interpreted with caution. We did not have information on other diagnostic 
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subtypes such as melancholia or atypical depression, which may be important with respect to the 
biological heterogeneity of MDD, and will need further research. 
While we did not find case-control differences of brain structural asymmetry in this study, functional 
asymmetries may still play an important role in MDD. Relations between structural and functional 
variability of the brain are subtle and complex (34-37). As mentioned in the introduction, various 
studies of depression have reported case-control differences in the asymmetry of frontal 
electrophysiological patterns (11, 14). The number of pyramidal cells, the number of synapses per 
cell, and their firing patterns are thought to influence cortical EEG recordings (38). A difference in the 
number of pyramidal cells may also affect cortical thickness (39). In fact, an inverse relation between 
cortical thickness and EEG alpha power has been reported for some cortical regions (40). However, a 
recent meta-analysis of frontal alpha asymmetry as a diagnostic marker in depression (16 studies, 
MDD: n = 1883, controls: n = 2161) found no significant difference between individuals with MDD 
and controls (16). Other reviews also point to inconsistencies or problems in studies of frontal alpha 
asymmetries in depression (15, 41), although most have been studies of the resting state, while there 
is evidence that EEG differences are stronger during cognitive or emotional processing tasks (42, 43). 
A recent study which made use of resting state fMRI reported that certain bilateral changes, which 
were found between 709 MDD individuals and 725 controls, would require a minimum of 400 
individuals per group to be detectable, and also that brain–clinical variable relationships exhibited 
poor cross-centre reproducibility (44). Clearly, large scale studies are necessary for brain imaging 
research into disorder associations, to reach reliable conclusions.  
As regards asymmetry specifically, it is unclear how altered functional laterality might relate to MDD 
in terms of cause, effect, or correlation due to shared underlying factors. The average form of human 
brain laterality is probably established in the embryo, as indicated by in utero behavioural data (45, 
46), as well as neuroanatomical studies of foetuses (47, 48), and gene expression analysis in which 
left and right-sided samples from the embryonic central nervous system are contrasted (49-51). The 
typical form of human brain asymmetry is characterised by left-hemisphere language dominance (in 
more than 85% of people) (52), right-handedness (also roughly 85% of people) (53), and a particular 
anatomical pattern involving both subcortical and cerebral cortical features (23, 24). However, 
human brain laterality is also highly variable between individuals. Factors that cause variation around 
the average form are largely unknown, and heritability estimates are generally low to modest for 
both functional and structural aspects, while age and sex have significant but subtle effects (10, 23, 
24). 
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We did not consider handedness as a factor in our models, as handedness did not show an effect on 
brain anatomical laterality in an analysis of over 17,000 subjects from healthy control and population 
datasets, also performed by the ENIGMA consortium (24). Data on handedness were limited for 
many of the datasets in the present study. 
In a multi-centre study such as ours, the between-centre variability may result in reduced statistical 
power relative to an equally sized single-centre study, but no single centre has been able to collect 
such large samples alone. In addition, multi-centre studies can be representative of real-world 
heterogeneity, with potentially more generalizable findings than single-centre studies (54). 
Conclusions 
Although the  present study examined a large sample size, with 80% power a priori to detect case-
control differences in the order of Cohen’s d=0.1, we found no significant differences between 
individuals with MDD and controls in asymmetries of cerebral cortical thickness and surface area 
measures, nor for subcortical volume asymmetries. Our study illustrates how high-powered and 
systematic studies can yield clearer findings in human clinical neuroscience, where previous studies 
had provided a mixed picture. 
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Figure Legends 
Figure 1. Effect sizes (as Cohen’s d) for regional asymmetry differences in cortical thickness and 
surface area, between MDD individuals and unaffected controls. A positive effect means that 
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individuals with MDD were more leftward/less rightward asymmetrical than controls. From top to 
bottom: lateral, medial, inferior, fronto-lateral views. Note that all Cohen’s d values ranged from -
0.081 to 0.085, and that none of the differences between individuals with MDD and controls were 
significant after adjustment for multiple testing across regions.  
List of Tables 
Table 1 Cohen’s d and p-values for the effects of diagnosis on AIs of subcortical volumes. 
Table 2 Cohen’s d and p-values for the effects of diagnosis on AIs of cortical surface areas  
Table 3 Cohen’s d and p-values for the effects of diagnosis on AIs of cortical thicknesses 
 
References 
1.  American Psychiatric Association t: Diagnostic and statistical manual of mental disorders. 5th ed. 
Washington DC, USA2013. 
2.  Verduijn J, Verhoeven JE, Milaneschi Y, Schoevers RA, van Hemert AM, Beekman ATF, Penninx B. 
Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery 
is the exception rather than the rule. BMC medicine. 2017;15:215. 
3.  Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annual review of public 
health. 2013;34:119-138. 
4.  Zhang FF, Peng W, Sweeney JA, Jia ZY, Gong QY. Brain structure alterations in depression: 
Psychoradiological evidence. CNS Neurosci Ther. 2018;24:994-1003. 
5.  Biberacher V, Schmidt P, Keshavan A, Boucard CC, Righart R, Samann P, Preibisch C, Frobel D, Aly 
L, Hemmer B, Zimmer C, Henry RG, Muhlau M. Intra- and interscanner variability of magnetic 
resonance imaging based volumetry in multiple sclerosis. Neuroimage. 2016;142:188-197. 
6.  Schmaal L, Veltman DJ, van Erp TG, Samann PG, Frodl T, Jahanshad N, Loehrer E, Tiemeier H, 
Hofman A, Niessen WJ, Vernooij MW, Ikram MA, Wittfeld K, Grabe HJ, Block A, Hegenscheid K, 
Volzke H, Hoehn D, Czisch M, Lagopoulos J, Hatton SN, Hickie IB, Goya-Maldonado R, Kramer B, 
Gruber O, Couvy-Duchesne B, Renteria ME, Strike LT, Mills NT, de Zubicaray GI, McMahon KL, 
20 
 
Medland SE, Martin NG, Gillespie NA, Wright MJ, Hall GB, MacQueen GM, Frey EM, Carballedo A, van 
Velzen LS, van Tol MJ, van der Wee NJ, Veer IM, Walter H, Schnell K, Schramm E, Normann C, Schoepf 
D, Konrad C, Zurowski B, Nickson T, McIntosh AM, Papmeyer M, Whalley HC, Sussmann JE, 
Godlewska BR, Cowen PJ, Fischer FH, Rose M, Penninx BW, Thompson PM, Hibar DP. Subcortical 
brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder 
working group. Mol Psychiatry. 2016;21:806-812. 
7.  Schmaal L, Hibar DP, Samann PG, Hall GB, Baune BT, Jahanshad N, Cheung JW, van Erp TGM, Bos 
D, Ikram MA, Vernooij MW, Niessen WJ, Tiemeier H, Hofman A, Wittfeld K, Grabe HJ, Janowitz D, 
Bulow R, Selonke M, Volzke H, Grotegerd D, Dannlowski U, Arolt V, Opel N, Heindel W, Kugel H, 
Hoehn D, Czisch M, Couvy-Duchesne B, Renteria ME, Strike LT, Wright MJ, Mills NT, de Zubicaray GI, 
McMahon KL, Medland SE, Martin NG, Gillespie NA, Goya-Maldonado R, Gruber O, Kramer B, Hatton 
SN, Lagopoulos J, Hickie IB, Frodl T, Carballedo A, Frey EM, van Velzen LS, Penninx B, van Tol MJ, van 
der Wee NJ, Davey CG, Harrison BJ, Mwangi B, Cao B, Soares JC, Veer IM, Walter H, Schoepf D, 
Zurowski B, Konrad C, Schramm E, Normann C, Schnell K, Sacchet MD, Gotlib IH, MacQueen GM, 
Godlewska BR, Nickson T, McIntosh AM, Papmeyer M, Whalley HC, Hall J, Sussmann JE, Li M, Walter 
M, Aftanas L, Brack I, Bokhan NA, Thompson PM, Veltman DJ. Cortical abnormalities in adults and 
adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA 
Major Depressive Disorder Working Group. Mol Psychiatry. 2017;22:900-909. 
8.  Agcaoglu O, Miller R, Damaraju E, Rashid B, Bustillo J, Cetin MS, Van Erp TGM, McEwen S, Preda A, 
Ford JM, Lim KO, Manoach DS, Mathalon DH, Potkin SG, Calhoun VD. Decreased hemispheric 
connectivity and decreased intra- and inter- hemisphere asymmetry of resting state functional 
network connectivity in schizophrenia. Brain Imaging Behav. 2018;12:615-630. 
9.  Dougherty CC, Evans DW, Katuwal GJ, Michael AM. Asymmetry of fusiform structure in autism 
spectrum disorder: trajectory and association with symptom severity. Molecular autism. 2016;7:28. 
10.  Rentería ME. Cerebral Asymmetry: A Quantitative, Multifactorial, and Plastic Brain Phenotype. 
Twin Research and Human Genetics. 2012;15:401-413. 
21 
 
11.  Jaworska N, Blier P, Fusee W, Knott V. alpha Power, alpha asymmetry and anterior cingulate 
cortex activity in depressed males and females. J Psychiatr Res. 2012;46:1483-1491. 
12.  Deslandes AC, de Moraes H, Pompeu FAMS, Ribeiro P, Cagy M, Capitão C, Alves H, Piedade RAM, 
Laks J. Electroencephalographic frontal asymmetry and depressive symptoms in the elderly. 
Biological Psychology. 2008;79:317-322. 
13.  Vuga M, Fox NA, F. Cohn J, George CJ, Levenstein RM, Kovacs M. Long-term stability of frontal 
electroencephalographic asymmetry in adults with a history of depression and controls. International 
Journal of Psychophysiology. 2006;59:107-115. 
14.  Grunewald BD, Greimel E, Trinkl M, Bartling J, Grossheinrich N, Schulte-Korne G. Resting frontal 
EEG asymmetry patterns in adolescents with and without major depression. Biol Psychol. 
2018;132:212-216. 
15.  Jesulola E, Sharpley CF, Bitsika V, Agnew LL, Wilson P. Frontal alpha asymmetry as a pathway to 
behavioural withdrawal in depression: Research findings and issues. Behavioural Brain Research. 
2015;292:56-67. 
16.  van der Vinne N, Vollebregt MA, van Putten M, Arns M. Frontal alpha asymmetry as a diagnostic 
marker in depression: Fact or fiction? A meta-analysis. NeuroImage Clinical. 2017;16:79-87. 
17.  Du L, Liu H, Du W, Chao F, Zhang L, Wang K, Huang C, Gao Y, Tang Y. Stimulated left DLPFC-
nucleus accumbens functional connectivity predicts the anti-depression and anti-anxiety effects of 
rTMS for depression. Transl Psychiatry. 2018;7:3. 
18.  Bruder GE, Stewart JW, McGrath PJ. Right brain, left brain in depressive disorders: Clinical and 
theoretical implications of behavioral, electrophysiological and neuroimaging findings. Neuroscience 
and biobehavioral reviews. 2017;78:178-191. 
19.  Coan JA, Allen JJ. Frontal EEG asymmetry and the behavioral activation and inhibition systems. 
Psychophysiology. 2003;40:106-114. 
20.  Davidson RJ. Anterior electrophysiological asymmetries, emotion, and depression: conceptual 
and methodological conundrums. Psychophysiology. 1998;35:607-614. 
22 
 
21.  Liu W, Mao Y, Wei D, Yang J, Du X, Xie P, Qiu J. Structural Asymmetry of Dorsolateral Prefrontal 
Cortex Correlates with Depressive Symptoms: Evidence from Healthy Individuals and Patients with 
Major Depressive Disorder. Neuroscience Bulletin. 2016;32:217-226. 
22.  Kumar A, Bilker W, Lavretsky H, Gottlieb G. Volumetric asymmetries in late-onset mood 
disorders: an attenuation of frontal asymmetry with depression severity. Psychiatry Res. 
2000;100:41-47. 
23.  Guadalupe T, Mathias SR, vanErp TGM, Whelan CD, Zwiers MP, Abe Y, Abramovic L, Agartz I, 
Andreassen OA, Arias-Vasquez A, Aribisala BS, Armstrong NJ, Arolt V, Artiges E, Ayesa-Arriola R, 
Baboyan VG, Banaschewski T, Barker G, Bastin ME, Baune BT, Blangero J, Bokde ALW, Boedhoe PSW, 
Bose A, Brem S, Brodaty H, Bromberg U, Brooks S, Buchel C, Buitelaar J, Calhoun VD, Cannon DM, 
Cattrell A, Cheng Y, Conrod PJ, Conzelmann A, Corvin A, Crespo-Facorro B, Crivello F, Dannlowski U, 
de Zubicaray GI, de Zwarte SMC, Deary IJ, Desrivieres S, Doan NT, Donohoe G, Dorum ES, Ehrlich S, 
Espeseth T, Fernandez G, Flor H, Fouche JP, Frouin V, Fukunaga M, Gallinat J, Garavan H, Gill M, 
Suarez AG, Gowland P, Grabe HJ, Grotegerd D, Gruber O, Hagenaars S, Hashimoto R, Hauser TU, 
Heinz A, Hibar DP, Hoekstra PJ, Hoogman M, Howells FM, Hu H, Hulshoff Pol HE, Huyser C, Ittermann 
B, Jahanshad N, Jonsson EG, Jurk S, Kahn RS, Kelly S, Kraemer B, Kugel H, Kwon JS, Lemaitre H, Lesch 
KP, Lochner C, Luciano M, Marquand AF, Martin NG, Martinez-Zalacain I, Martinot JL, Mataix-Cols D, 
Mather K, McDonald C, McMahon KL, Medland SE, Menchon JM, Morris DW, Mothersill O, Maniega 
SM, Mwangi B, Nakamae T, Nakao T, Narayanaswaamy JC, Nees F, Nordvik JE, Onnink AMH, Opel N, 
Ophoff R, Paillere Martinot ML, Papadopoulos Orfanos D, Pauli P, Paus T, Poustka L, Reddy JY, 
Renteria ME, Roiz-Santianez R, Roos A, Royle NA, Sachdev P, Sanchez-Juan P, Schmaal L, Schumann 
G, Shumskaya E, Smolka MN, Soares JC, Soriano-Mas C, Stein DJ, Strike LT, Toro R, Turner JA, Tzourio-
Mazoyer N, Uhlmann A, Hernandez MV, van den Heuvel OA, van der Meer D, van Haren NEM, 
Veltman DJ, Venkatasubramanian G, Vetter NC, Vuletic D, Walitza S, Walter H, Walton E, Wang Z, 
Wardlaw J, Wen W, Westlye LT, Whelan R, Wittfeld K, Wolfers T, Wright MJ, Xu J, Xu X, Yun JY, Zhao 
J, Franke B, Thompson PM, Glahn DC, Mazoyer B, Fisher SE, Francks C. Human subcortical brain 
23 
 
asymmetries in 15,847 people worldwide reveal effects of age and sex. Brain Imaging Behav. 
2017;11:1497-1514. 
24.  Kong X-Z, Mathias S, Guadalupe T, Group ELW, Rubia K, Glahn D, Franke B, Crivello F, Tzourio-
Mazoyer N, Fisher S, Thompson P, Francks C. Mapping Cortical Brain Asymmetry in 17,141 Healthy 
Individuals Worldwide via the ENIGMA Consortium. Proceedings of the National Academy of Sciences 
of the United States of America. 2018;115:E5154-E5163. 
25.  Romans SE, Tyas J, Cohen MM, Silverstone T. Gender differences in the symptoms of major 
depressive disorder. The Journal of nervous and mental disease. 2007;195:905-911. 
26.  Albert PR. Why is depression more prevalent in women? Journal of Psychiatry & Neuroscience : 
JPN. 2015;40:219-221. 
27.  Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, 
Maguire RP, Hyman BT, Albert MS, Killiany RJ. An automated labeling system for subdividing the 
human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage. 2006;31:968-
980. 
28.  Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface 
reconstruction. Neuroimage. 1999;9:179-194. 
29.  Fischl B. FreeSurfer. Neuroimage. 2012;62:774-781. 
30.  Hoaglin DC, Iglewicz B. Fine-Tuning Some Resistant Rules for Outlier Labeling. Journal of the 
American Statistical Association. 1987;82:1147-1149. 
31.  Chambers JM, Hastie TJ: Statistical models in S. Pacific Grove, California, USA, Wadsworth & 
Brooks/Cole; 1992. 
32.  Panizzon MS, Fennema-Notestine C, Eyler LT, Jernigan TL, Prom-Wormley E, Neale M, Jacobson 
K, Lyons MJ, Grant MD, Franz CE, Xian H, Tsuang M, Fischl B, Seidman L, Dale A, Kremen WS. Distinct 
Genetic Influences on Cortical Surface Area and Cortical Thickness. Cerebral Cortex. 2009;19:2728-
2735. 
24 
 
33.  Zhao Y, Chen L, Zhang W, Xiao Y, Shah C, Zhu H, Yuan M, Sun H, Yue Q, Jia Z, Zhang W, Kuang W, 
Gong Q, Lui S. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major 
Depressive Disorder or Social Anxiety Disorder. EBioMedicine. 2017;21:228-235. 
34.  Chen C, Omiya Y. Brain asymmetry in cortical thickness is correlated with cognitive function. 
Front Hum Neurosci. 2014;8:877. 
35.  Plessen KJ, Hugdahl K, Bansal R, Hao X, Peterson BS. Sex, Age, and Cognitive Correlates of 
Asymmetries in Thickness of the Cortical Mantle Across the Life Span. The Journal of Neuroscience. 
2014;34:6294-6302. 
36.  Tzourio-Mazoyer N, Crivello F, Mazoyer B. Is the planum temporale surface area a marker of 
hemispheric or regional language lateralization? Brain Structure and Function. 2018;223:1217-1228. 
37.  Batista-Garcia-Ramo K, Fernandez-Verdecia CI. What We Know About the Brain Structure-
Function Relationship. Behav Sci (Basel). 2018;8. 
38.  Kenemans L: A primer on EEG and related measures of brain activity. Utrecht University; 2013. 
39.  Shin DM, Korada S, Raballo R, Shashikant CS, Simeone A, Taylor JR, Vaccarino F. Loss of 
Glutamatergic Pyramidal Neurons in Frontal and Temporal Cortex Resulting from Attenuation of 
FGFR1 Signaling Is Associated with Spontaneous Hyperactivity in Mice. The Journal of Neuroscience. 
2004;24:2247-2258. 
40.  Bruder GE, Bansal R, Tenke CE, Liu J, Hao X, Warner V, Peterson BS, Weissman MM. Relationship 
of resting EEG with anatomical MRI measures in individuals at high and low risk for depression. 
Human Brain Mapping. 2012;33:1325-1333. 
41.  Koo PC, Thome J, Berger C, Foley P, Hoeppner J. Current source density analysis of resting state 
EEG in depression: a review. Journal of neural transmission (Vienna, Austria : 1996). 2017;124:109-
118. 
42.  Coan JA, Allen JJ, McKnight PE. A capability model of individual differences in frontal EEG 
asymmetry. Biol Psychol. 2006;72:198-207. 
25 
 
43.  Manna CB, Tenke CE, Gates NA, Kayser J, Borod JC, Stewart JW, McGrath PJ, Bruder GE. EEG 
hemispheric asymmetries during cognitive tasks in depressed patients with high versus low trait 
anxiety. Clinical EEG and neuroscience. 2010;41:196-202. 
44.  Xia M, Si T, Sun X, Ma Q, Liu B, Wang L, Meng J, Chang M, Huang X, Chen Z, Tang Y, Xu K, Gong Q, 
Wang F, Qiu J, Xie P, Li L, He Y, Group DI-MDDW. Reproducibility of functional brain alterations in 
major depressive disorder: Evidence from a multisite resting-state functional MRI study with 1,434 
individuals. Neuroimage. 2019;189:700-714. 
45.  Hepper PG. The developmental origins of laterality: Fetal handedness. Developmental 
Psychobiology. 2013;55:588-595. 
46.  Parma V, Brasselet R, Zoia S, Bulgheroni M, Castiello U. The origin of human handedness and its 
role in pre-birth motor control. Sci Rep. 2017;7:16804. 
47.  Abu-Rustum RS, Ziade MF, Abu-Rustum SE. Reference Values for the Right and Left Fetal Choroid 
Plexus at 11 to 13 Weeks An Early Sign of "Developmental" Laterality? J Ultras Med. 2013;32:1623-
1629. 
48.  Kasprian G, Langs G, Brugger PC, Bittner M, Weber M, Arantes M, Prayer D. The prenatal origin 
of hemispheric asymmetry: an in utero neuroimaging study. Cereb Cortex. 2011;21:1076-1083. 
49.  de Kovel CGF, Lisgo S, Karlebach G, Ju J, Cheng G, Fisher SE, Francks C. Left-Right Asymmetry of 
Maturation Rates in Human Embryonic Neural Development. Biol Psychiatry. 2017;82:204-212. 
50.  Ocklenburg S, Schmitz J, Moinfar Z, Moser D, Klose R, Lor S, Kunz G, Tegenthoff M, Faustmann P, 
Francks C, Epplen JT, Kumsta R, Gunturkun O. Epigenetic regulation of lateralized fetal spinal gene 
expression underlies hemispheric asymmetries. Elife. 2017;6. 
51.  Sun T, Patoine C, Abu-Khalil A, Visvader J, Sum E, Cherry TJ, Orkin SH, Geschwind DH, Walsh CA. 
Early Asymmetry of Gene Transcription in Embryonic Human Left and Right Cerebral Cortex. Science. 
2005;308:1794-1798. 
26 
 
52.  Mazoyer B, Zago L, Jobard G, Crivello F, Joliot M, Perchey G, Mellet E, Petit L, Tzourio-Mazoyer N. 
Gaussian mixture modeling of hemispheric lateralization for language in a large sample of healthy 
individuals balanced for handedness. PLoS One. 2014;9:e101165. 
53.  Gilbert AN, Wysocki CJ. Hand preference and age in the United States. Neuropsychologia. 
1992;30:601-608. 
54.  Costafreda S. Pooling fMRI data: meta-analysis, mega-analysis and multi-center studies. Frontiers 
in Neuroinformatics. 2009;3:33. 
 
27 
 
Tables 
 
Table 1 Cohen’s d and p-values for the effects of diagnosis on AIs of subcortical volumes. A positive effect means that cases are more leftwards/less rightwards asymmetrical than controls. 
 All Males Females > 21 years ≤ 21 years 
Region d p d p d p d p d p 
accumbens 0.0009 0.972 -0.026 0.541 0.023 0.492 0.012 0.679 -0.004 0.948 
amygdala 0.0163 0.523 0.041 0.324 0.001 0.986 0.009 0.759 0.029 0.646 
caudate -0.0159 0.534 -0.018 0.654 -0.011 0.737 -0.008 0.771 -0.072 0.258 
hippocampus -0.0414 0.105 -0.112 0.007 -0.003 0.928 -0.037 0.187 -0.029 0.652 
lateral ventricles 0.0584 0.021 0.057 0.168 0.059 0.072 0.046 0.106 0.089 0.156 
pallidum -0.0224 0.391 -0.088 0.037 0.009 0.782 -0.003 0.930 -0.087 0.186 
putamen -0.0278 0.286 -0.099 0.018 0.012 0.723 -0.025 0.382 -0.026 0.691 
thalamus 0.0010 0.969 0.019 0.640 -0.016 0.631 0.002 0.934 -0.029 0.647 
  
28 
 
 
Table 2 Cohen’s d and p-values for the effects of diagnosis on AIs of cortical surface areas. A positive effect means that cases are more leftwards/less rightwards asymmetrical than controls. 
 
 All Males Females > 21 years ≤ 21 years 
Region d p d p d p d p d p 
total surface area 0.017 0.543 -0.035 0.475 0.052 0.188 0.017 0.580 0.069 0.295 
banks sts 0.004 0.879 0.009 0.858 -0.010 0.812 -0.013 0.680 0.072 0.300 
caudal anterior cingulate -0.022 0.434 -0.079 0.109 -0.012 0.763 -0.030 0.336 0.015 0.817 
caudal middle frontal 0.058 0.036 -0.024 0.634 0.104 0.009 0.044 0.152 0.139 0.035 
cuneus -0.081 0.003 -0.124 0.012 -0.051 0.201 -0.071 0.022 -0.047 0.480 
entorhinal -0.005 0.864 0.068 0.195 -0.029 0.498 -0.008 0.803 -0.009 0.888 
frontal pole -0.045 0.102 -0.044 0.371 -0.056 0.158 -0.027 0.379 -0.126 0.057 
fusiform -0.002 0.944 0.060 0.241 -0.041 0.309 0.030 0.341 -0.122 0.065 
inferior parietal -0.031 0.273 0.008 0.877 0.007 0.862 -0.044 0.159 0.028 0.668 
inferior temporal 0.037 0.185 0.057 0.246 0.035 0.379 0.029 0.343 0.085 0.197 
insula 0.046 0.098 0.072 0.141 0.013 0.744 0.065 0.035 0.008 0.899 
isthmus cingulate 0.003 0.918 0.068 0.166 0.055 0.167 0.004 0.890 0.039 0.553 
lateral occipital 0.000 0.986 0.033 0.500 -0.018 0.652 -0.003 0.930 0.029 0.659 
lateral orbitofrontal 0.004 0.891 0.034 0.488 -0.015 0.713 0.003 0.923 0.001 0.982 
lingual 0.010 0.730 -0.022 0.649 0.069 0.080 -0.003 0.913 0.069 0.297 
medial-orbitofrontal -0.019 0.503 0.025 0.612 -0.036 0.369 -0.045 0.152 0.082 0.212 
middle temporal -0.042 0.140 0.008 0.868 -0.099 0.016 -0.047 0.139 -0.038 0.578 
para-central 0.031 0.261 0.020 0.689 0.030 0.463 0.041 0.190 0.027 0.686 
parahippocampal -0.003 0.925 0.051 0.303 0.005 0.901 -0.028 0.372 0.078 0.239 
pars opercularis 0.023 0.409 0.013 0.794 0.024 0.541 0.009 0.757 0.051 0.440 
pars orbitalis 0.022 0.420 -0.014 0.773 0.022 0.571 0.019 0.526 0.023 0.727 
pars triangularis 0.006 0.841 -0.021 0.671 -0.015 0.701 -0.001 0.978 -0.001 0.990 
pericalcarine -0.031 0.265 0.018 0.718 -0.036 0.372 -0.025 0.424 -0.015 0.826 
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post-central -0.021 0.447 0.029 0.554 -0.013 0.744 -0.020 0.518 -0.001 0.985 
posterior cingulate -0.044 0.110 -0.060 0.216 -0.046 0.243 -0.046 0.136 -0.004 0.947 
pre-central 0.038 0.172 0.063 0.206 0.022 0.578 0.045 0.144 0.059 0.370 
pre-cuneus 0.005 0.851 -0.047 0.341 0.071 0.072 -0.021 0.498 0.084 0.202 
rostral anterior cingulate 0.014 0.626 -0.064 0.198 0.045 0.266 0.018 0.566 -0.005 0.941 
rostral middle frontal -0.062 0.026 -0.094 0.055 -0.026 0.506 -0.073 0.017 -0.005 0.944 
superior frontal 0.064 0.021 0.107 0.032 0.047 0.242 0.061 0.050 0.061 0.358 
superior parietal -0.020 0.463 -0.121 0.014 0.040 0.316 -0.015 0.620 -0.021 0.748 
superior temporal 0.017 0.565 -0.052 0.309 0.052 0.206 0.009 0.789 0.029 0.676 
supra-marginal 0.038 0.177 0.030 0.558 0.031 0.441 0.064 0.043 -0.093 0.166 
temporal pole -0.003 0.908 0.079 0.112 0.003 0.950 -0.016 0.609 0.041 0.530 
transverse temporal 0.008 0.770 -0.076 0.117 -0.018 0.651 0.017 0.569 -0.046 0.487 
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Table 3. Cohen’s d and p-values for the effects of diagnosis on AIs of cortical thickness. A positive effect means that cases are more leftwards/less rightwards asymmetrical than controls. 
 All Males Females > 21 years ≤ 21 years 
Region d p d p d p d p d p 
average thickness 0.028 0.307 0.070 0.111 -0.005 0.893 0.024 0.431 0.055 0.400 
banks sts 0.016 0.582 0.011 0.810 0.014 0.711 0.049 0.122 -0.103 0.134 
caudal anterior cingulate 0.079 0.004 0.083 0.059 0.077 0.030 0.070 0.021 0.097 0.142 
caudal middle frontal 0.017 0.537 -0.008 0.859 0.036 0.314 0.009 0.771 0.056 0.392 
cuneus -0.027 0.325 -0.020 0.655 -0.025 0.477 -0.019 0.529 -0.029 0.660 
entorhinal 0.010 0.733 0.018 0.691 0.006 0.868 0.004 0.894 0.046 0.492 
frontal pole 0.016 0.563 0.054 0.215 -0.018 0.609 0.020 0.513 0.051 0.442 
Fusiform 0.002 0.954 0.022 0.614 -0.009 0.802 0.004 0.905 -0.008 0.909 
inferior parietal -0.052 0.057 -0.048 0.273 -0.045 0.209 -0.050 0.104 -0.070 0.290 
inferior temporal 0.048 0.080 0.071 0.109 0.028 0.430 0.045 0.140 0.037 0.579 
Insula 0.005 0.850 0.039 0.378 -0.018 0.614 -0.003 0.924 0.039 0.560 
isthmus cingulate -0.017 0.527 -0.009 0.831 -0.033 0.348 -0.018 0.561 -0.064 0.328 
lateral occipital -0.013 0.645 -0.087 0.048 0.045 0.202 -0.027 0.370 0.022 0.738 
lateral orbitofrontal 0.044 0.108 0.068 0.119 0.033 0.350 0.058 0.056 0.049 0.456 
Lingual 0.019 0.482 -0.027 0.544 0.051 0.152 0.035 0.246 -0.030 0.648 
medial-orbitofrontal -0.053 0.054 -0.091 0.040 -0.021 0.562 -0.032 0.289 -0.076 0.249 
middle temporal -0.008 0.766 -0.019 0.676 -0.006 0.865 -0.003 0.926 -0.067 0.321 
para-central 0.001 0.983 0.062 0.160 -0.037 0.299 0.001 0.966 0.034 0.602 
parahippocampal 0.032 0.245 0.096 0.029 -0.002 0.946 0.038 0.215 0.064 0.336 
pars opercularis -0.041 0.135 -0.091 0.038 -0.024 0.494 -0.065 0.032 0.096 0.145 
pars orbitalis -0.010 0.714 -0.013 0.770 -0.011 0.765 -0.020 0.511 0.069 0.300 
pars triangularis -0.004 0.891 0.017 0.693 -0.024 0.501 -0.006 0.832 0.053 0.423 
pericalcarine 0.008 0.768 -0.013 0.772 0.025 0.484 0.012 0.693 -0.030 0.648 
post-central 0.047 0.091 0.063 0.151 0.026 0.461 0.044 0.149 0.064 0.330 
posterior cingulate 0.038 0.165 0.055 0.211 0.027 0.444 0.041 0.176 0.029 0.660 
pre-central 0.026 0.336 0.011 0.800 0.025 0.475 0.016 0.592 0.044 0.509 
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pre-cuneus -0.051 0.063 -0.007 0.881 -0.076 0.033 -0.055 0.070 -0.019 0.777 
rostral anterior cingulate -0.007 0.808 0.031 0.483 -0.027 0.451 -0.016 0.600 0.063 0.341 
rostral middle frontal -0.030 0.268 -0.039 0.378 -0.036 0.309 -0.021 0.493 -0.045 0.492 
superior frontal -0.011 0.691 0.063 0.153 -0.059 0.098 -0.008 0.781 0.028 0.674 
superior parietal 0.004 0.872 0.081 0.066 -0.047 0.188 0.011 0.711 -0.032 0.629 
superior temporal 0.085 0.003 0.090 0.049 0.071 0.056 0.068 0.033 0.133 0.051 
supra-marginal 0.021 0.445 0.077 0.084 -0.016 0.651 0.011 0.712 0.029 0.667 
temporal pole -0.010 0.730 -0.024 0.581 0.009 0.804 -0.003 0.924 -0.033 0.618 
transverse temporal 0.037 0.174 0.078 0.078 0.008 0.825 0.019 0.537 0.111 0.092 
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Figure 1 
 
